Invention Grant
- Patent Title: Arylpiperazines having activity at the serotonin 1A receptor
-
Application No.: US10419063Application Date: 2003-04-16
-
Publication No.: US07001908B2Publication Date: 2006-02-21
- Inventor: Alexander Glenn Godfrey , Daniel Timothy Kohlman , John Cunningham O'Toole , Yao-Chang Xu , Tony Yantao Zhang
- Applicant: Alexander Glenn Godfrey , Daniel Timothy Kohlman , John Cunningham O'Toole , Yao-Chang Xu , Tony Yantao Zhang
- Applicant Address: US CA San Diego US IN Indianapolis
- Assignee: Avera Pharmaceuticals, Inc.,Eli Lilly and Company
- Current Assignee: Avera Pharmaceuticals, Inc.,Eli Lilly and Company
- Current Assignee Address: US CA San Diego US IN Indianapolis
- Agency: Knobbe Martens Olson & Bear LLP
- Main IPC: A61K31/497
- IPC: A61K31/497 ; C07D401/00
Abstract:
A series of aryl piperazine compounds are effective pharmaceuticals for the treatment of conditions related to or affected by the serotonin 1A receptor; the compounds are particularly effective antagonists at that receptor, and are particularly useful for alleviating the symptoms of nicotine and tobacco withdrawal.
Public/Granted literature
- US20040044009A1 Arylpiperazines having activity at the serotonin 1A receptor Public/Granted day:2004-03-04
Information query
IPC分类:
